کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2081450 | 1545134 | 2012 | 8 صفحه PDF | دانلود رایگان |

Base excision repair (BER) is the fundamental pathway responsible for the elimination of damaged DNA bases and repair of DNA single-strand breaks generated spontaneously or produced by DNA-damaging agents. Among the essential enzymes that are required to achieve the BER reaction is DNA polymerase beta (pol β), which has been regarded as a potential therapeutic target. More than 60 pol β-inhibitors have been identified so far; however, most of them are either not potent or not specific enough to become a drug. In this article we compile an essential knowledge base regarding the structures, the modes of inhibition and the activities of these pharmacologically interesting molecules.
► Structure of DNA polymerase beta.
► Background of DNA polymerase beta inhibitors.
► Recent work on DNA polymerase beta inhibitors.
Journal: Drug Discovery Today - Volume 17, Issues 15–16, August 2012, Pages 913–920